 Trevor Nydam
Concepts (341)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 45 | 2026 | 814 | 8.610 |
Why?
| | Tissue and Organ Procurement | 10 | 2026 | 331 | 2.690 |
Why?
| | Kidney Transplantation | 15 | 2025 | 698 | 2.540 |
Why?
| | Obesity, Morbid | 7 | 2025 | 278 | 2.520 |
Why?
| | Gastric Bypass | 4 | 2023 | 123 | 2.380 |
Why?
| | Thrombelastography | 14 | 2025 | 175 | 2.290 |
Why?
| | Living Donors | 8 | 2022 | 279 | 1.880 |
Why?
| | Tissue Plasminogen Activator | 7 | 2023 | 239 | 1.820 |
Why?
| | Organ Preservation | 6 | 2026 | 128 | 1.790 |
Why?
| | Tissue Donors | 11 | 2025 | 412 | 1.780 |
Why?
| | Blood Coagulation Disorders | 5 | 2025 | 191 | 1.690 |
Why?
| | Death | 4 | 2023 | 128 | 1.510 |
Why?
| | Fibrinolysis | 6 | 2025 | 162 | 1.350 |
Why?
| | Perfusion | 4 | 2026 | 242 | 1.290 |
Why?
| | Donor Selection | 6 | 2025 | 78 | 1.190 |
Why?
| | Bariatric Surgery | 3 | 2025 | 233 | 1.170 |
Why?
| | Graft Survival | 12 | 2025 | 522 | 1.080 |
Why?
| | Gastrectomy | 7 | 2025 | 143 | 1.060 |
Why?
| | Cold Ischemia | 5 | 2026 | 39 | 0.990 |
Why?
| | Carcinoma, Hepatocellular | 8 | 2023 | 365 | 0.980 |
Why?
| | End Stage Liver Disease | 7 | 2025 | 85 | 0.930 |
Why?
| | Kidney Failure, Chronic | 5 | 2025 | 600 | 0.920 |
Why?
| | Blood Transfusion | 6 | 2025 | 401 | 0.890 |
Why?
| | Liver Neoplasms | 8 | 2023 | 758 | 0.810 |
Why?
| | Kidney | 8 | 2022 | 1507 | 0.800 |
Why?
| | Delayed Graft Function | 3 | 2022 | 34 | 0.780 |
Why?
| | Hepatitis C | 3 | 2022 | 253 | 0.760 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 34 | 0.760 |
Why?
| | Resuscitation | 2 | 2024 | 301 | 0.710 |
Why?
| | Organ Transplantation | 3 | 2025 | 252 | 0.680 |
Why?
| | Reperfusion | 1 | 2020 | 46 | 0.650 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 52 | 0.630 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 149 | 0.630 |
Why?
| | Postoperative Complications | 5 | 2025 | 2887 | 0.620 |
Why?
| | Humans | 81 | 2026 | 143560 | 0.620 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 100 | 0.610 |
Why?
| | Decision Support Techniques | 7 | 2025 | 438 | 0.600 |
Why?
| | Graft Rejection | 2 | 2020 | 551 | 0.590 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 24 | 0.580 |
Why?
| | Heart Failure | 2 | 2023 | 2131 | 0.580 |
Why?
| | Apoptosis | 5 | 2021 | 2519 | 0.570 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 47 | 0.570 |
Why?
| | Caspase Inhibitors | 1 | 2018 | 81 | 0.560 |
Why?
| | Blood Coagulation | 6 | 2023 | 271 | 0.550 |
Why?
| | Pneumoperitoneum | 1 | 2017 | 12 | 0.540 |
Why?
| | Klebsiella Infections | 1 | 2017 | 26 | 0.540 |
Why?
| | Cholecystitis | 1 | 2017 | 23 | 0.540 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2018 | 81 | 0.540 |
Why?
| | Thrombophilia | 1 | 2018 | 90 | 0.530 |
Why?
| | Cholecystectomy | 1 | 2017 | 58 | 0.530 |
Why?
| | Quinolines | 1 | 2018 | 171 | 0.520 |
Why?
| | Middle Aged | 35 | 2026 | 35343 | 0.520 |
Why?
| | Liver | 7 | 2022 | 1864 | 0.520 |
Why?
| | Heart Transplantation | 1 | 2023 | 726 | 0.510 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2024 | 1095 | 0.500 |
Why?
| | Transplant Recipients | 3 | 2025 | 183 | 0.500 |
Why?
| | Retrospective Studies | 24 | 2026 | 16740 | 0.490 |
Why?
| | Health Services Accessibility | 4 | 2026 | 1049 | 0.480 |
Why?
| | Wounds and Injuries | 5 | 2025 | 941 | 0.480 |
Why?
| | Renal Nutcracker Syndrome | 2 | 2025 | 8 | 0.450 |
Why?
| | Parents | 2 | 2020 | 1456 | 0.420 |
Why?
| | Brain Death | 4 | 2025 | 51 | 0.420 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2024 | 266 | 0.410 |
Why?
| | Male | 44 | 2026 | 71501 | 0.390 |
Why?
| | Registries | 2 | 2025 | 2238 | 0.380 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 831 | 0.360 |
Why?
| | Creatinine | 4 | 2023 | 494 | 0.360 |
Why?
| | Social Determinants of Health | 2 | 2026 | 293 | 0.360 |
Why?
| | Pancreatic Neoplasms | 4 | 2024 | 924 | 0.350 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2014 | 1226 | 0.350 |
Why?
| | Saline Solution, Hypertonic | 3 | 2014 | 41 | 0.350 |
Why?
| | Treatment Outcome | 17 | 2025 | 11365 | 0.340 |
Why?
| | Obesity | 6 | 2025 | 3042 | 0.340 |
Why?
| | Female | 37 | 2026 | 77252 | 0.340 |
Why?
| | Waiting Lists | 6 | 2025 | 255 | 0.330 |
Why?
| | Multiple Organ Failure | 1 | 2011 | 127 | 0.320 |
Why?
| | NF-kappa B | 4 | 2014 | 685 | 0.310 |
Why?
| | Adult | 25 | 2026 | 40012 | 0.310 |
Why?
| | Predictive Value of Tests | 7 | 2025 | 2086 | 0.310 |
Why?
| | Adenocarcinoma | 3 | 2024 | 911 | 0.300 |
Why?
| | Time Factors | 13 | 2026 | 7032 | 0.300 |
Why?
| | Ablation Techniques | 2 | 2020 | 36 | 0.300 |
Why?
| | Thrombocytopenia | 1 | 2011 | 209 | 0.290 |
Why?
| | Warm Ischemia | 2 | 2020 | 18 | 0.290 |
Why?
| | Renal Veins | 2 | 2025 | 18 | 0.290 |
Why?
| | United States | 15 | 2025 | 15554 | 0.290 |
Why?
| | Thrombosis | 3 | 2022 | 401 | 0.280 |
Why?
| | Risk Factors | 13 | 2026 | 10644 | 0.270 |
Why?
| | Transplantation, Autologous | 2 | 2025 | 284 | 0.250 |
Why?
| | Aged | 18 | 2026 | 25322 | 0.250 |
Why?
| | Survival Rate | 5 | 2024 | 2003 | 0.250 |
Why?
| | Markov Chains | 5 | 2025 | 126 | 0.240 |
Why?
| | Necrosis | 3 | 2021 | 247 | 0.240 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.230 |
Why?
| | Fibrinolysin | 1 | 2025 | 21 | 0.230 |
Why?
| | Epithelial Cells | 3 | 2014 | 1125 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 378 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 373 | 0.220 |
Why?
| | Metabolomics | 3 | 2019 | 715 | 0.220 |
Why?
| | Flank Pain | 1 | 2024 | 9 | 0.220 |
Why?
| | Weight Loss | 4 | 2025 | 812 | 0.220 |
Why?
| | Colonoscopy | 1 | 2007 | 254 | 0.220 |
Why?
| | Prospective Studies | 4 | 2020 | 7900 | 0.210 |
Why?
| | Tumor Burden | 3 | 2020 | 319 | 0.210 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 75 | 0.200 |
Why?
| | Lung | 3 | 2014 | 4101 | 0.200 |
Why?
| | Salvage Therapy | 2 | 2024 | 156 | 0.200 |
Why?
| | Choledochostomy | 1 | 2022 | 10 | 0.190 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2022 | 26 | 0.190 |
Why?
| | Caspase 1 | 2 | 2021 | 147 | 0.190 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2022 | 89 | 0.190 |
Why?
| | Risk Assessment | 7 | 2022 | 3577 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2022 | 764 | 0.190 |
Why?
| | Bile Ducts | 1 | 2022 | 67 | 0.190 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.180 |
Why?
| | Allografts | 1 | 2023 | 151 | 0.180 |
Why?
| | Preoperative Period | 2 | 2019 | 145 | 0.180 |
Why?
| | Hemostatics | 1 | 2022 | 61 | 0.180 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 270 | 0.170 |
Why?
| | Severity of Illness Index | 3 | 2025 | 2936 | 0.170 |
Why?
| | Stents | 1 | 2025 | 543 | 0.170 |
Why?
| | Nephrectomy | 2 | 2020 | 159 | 0.170 |
Why?
| | Surgeons | 1 | 2025 | 336 | 0.160 |
Why?
| | Intraoperative Period | 1 | 2020 | 68 | 0.160 |
Why?
| | Reperfusion Injury | 2 | 2021 | 292 | 0.160 |
Why?
| | Cell Line | 3 | 2018 | 2897 | 0.160 |
Why?
| | Computer Systems | 1 | 2020 | 53 | 0.160 |
Why?
| | Viscosity | 1 | 2020 | 93 | 0.160 |
Why?
| | Liver Function Tests | 1 | 2020 | 107 | 0.160 |
Why?
| | Models, Animal | 2 | 2020 | 392 | 0.160 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.160 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 72 | 0.160 |
Why?
| | Hepacivirus | 1 | 2022 | 242 | 0.160 |
Why?
| | Caspase 3 | 2 | 2018 | 251 | 0.160 |
Why?
| | Pancreatectomy | 2 | 2024 | 267 | 0.160 |
Why?
| | Shock, Hemorrhagic | 2 | 2016 | 200 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 1051 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 276 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 109 | 0.150 |
Why?
| | Thromboembolism | 1 | 2020 | 126 | 0.150 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 328 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 304 | 0.150 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 414 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5308 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 6043 | 0.140 |
Why?
| | Incidence | 2 | 2025 | 2844 | 0.130 |
Why?
| | Klebsiella pneumoniae | 1 | 2017 | 46 | 0.130 |
Why?
| | Case-Control Studies | 3 | 2023 | 3625 | 0.130 |
Why?
| | Platelet Count | 2 | 2022 | 92 | 0.130 |
Why?
| | Critical Care | 1 | 2023 | 684 | 0.130 |
Why?
| | Plasma | 2 | 2016 | 222 | 0.130 |
Why?
| | Drug Overdose | 1 | 2021 | 362 | 0.130 |
Why?
| | Goals | 1 | 2018 | 182 | 0.120 |
Why?
| | Young Adult | 7 | 2024 | 13972 | 0.120 |
Why?
| | Hepatectomy | 1 | 2018 | 258 | 0.120 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.120 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 44 | 0.120 |
Why?
| | Airway Extubation | 1 | 2016 | 60 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 50 | 0.110 |
Why?
| | Renal Artery | 1 | 2015 | 43 | 0.110 |
Why?
| | Isoantibodies | 1 | 2015 | 57 | 0.110 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 341 | 0.110 |
Why?
| | ABO Blood-Group System | 1 | 2015 | 53 | 0.110 |
Why?
| | Rewarming | 1 | 2014 | 21 | 0.110 |
Why?
| | Microsurgery | 1 | 2015 | 78 | 0.110 |
Why?
| | Early Detection of Cancer | 1 | 2019 | 445 | 0.110 |
Why?
| | Phosphorylation | 4 | 2014 | 1781 | 0.100 |
Why?
| | Kidney Tubules | 1 | 2014 | 117 | 0.100 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 184 | 0.100 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2015 | 141 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 361 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 577 | 0.100 |
Why?
| | Cholestasis | 1 | 2016 | 217 | 0.100 |
Why?
| | Erythrocyte Transfusion | 2 | 2016 | 211 | 0.100 |
Why?
| | Age Factors | 4 | 2021 | 3328 | 0.100 |
Why?
| | Osmolar Concentration | 1 | 2013 | 166 | 0.100 |
Why?
| | ROC Curve | 2 | 2025 | 603 | 0.100 |
Why?
| | Biomarkers | 3 | 2019 | 4241 | 0.090 |
Why?
| | Aortic Valve Stenosis | 1 | 2015 | 246 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2014 | 392 | 0.090 |
Why?
| | Metabolome | 1 | 2016 | 374 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1282 | 0.090 |
Why?
| | Autophagy | 1 | 2014 | 287 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 703 | 0.090 |
Why?
| | Microvessels | 1 | 2013 | 92 | 0.090 |
Why?
| | Sirolimus | 1 | 2013 | 278 | 0.090 |
Why?
| | Patient Selection | 1 | 2015 | 691 | 0.090 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 285 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1831 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4522 | 0.090 |
Why?
| | Animals | 9 | 2021 | 38010 | 0.090 |
Why?
| | Shock | 2 | 2024 | 105 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2804 | 0.070 |
Why?
| | Postoperative Period | 2 | 2020 | 361 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 859 | 0.070 |
Why?
| | Injury Severity Score | 1 | 2011 | 575 | 0.070 |
Why?
| | Hypoxia | 1 | 2016 | 1177 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2020 | 160 | 0.070 |
Why?
| | Odds Ratio | 1 | 2011 | 1060 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1511 | 0.070 |
Why?
| | Renal Dialysis | 2 | 2023 | 460 | 0.070 |
Why?
| | Mice | 6 | 2021 | 18378 | 0.070 |
Why?
| | Colonoscopes | 1 | 2007 | 5 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 420 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 447 | 0.070 |
Why?
| | Barium Sulfate | 1 | 2007 | 15 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2007 | 54 | 0.070 |
Why?
| | Mesentery | 1 | 2007 | 45 | 0.070 |
Why?
| | Cecum | 1 | 2007 | 33 | 0.070 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 438 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 280 | 0.060 |
Why?
| | Paraneoplastic Syndromes | 1 | 2007 | 12 | 0.060 |
Why?
| | Enema | 1 | 2007 | 46 | 0.060 |
Why?
| | Cause of Death | 2 | 2021 | 459 | 0.060 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 39 | 0.060 |
Why?
| | Blotting, Western | 1 | 2009 | 1223 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 72 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2009 | 589 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 510 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1136 | 0.060 |
Why?
| | Recurrence | 2 | 2023 | 1114 | 0.060 |
Why?
| | Quality of Life | 1 | 2018 | 3080 | 0.060 |
Why?
| | Logistic Models | 1 | 2011 | 2107 | 0.060 |
Why?
| | Survival Analysis | 2 | 2020 | 1332 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1192 | 0.060 |
Why?
| | Child | 6 | 2022 | 22725 | 0.060 |
Why?
| | Travel | 1 | 2026 | 145 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2019 | 740 | 0.050 |
Why?
| | Ampulla of Vater | 1 | 2024 | 36 | 0.050 |
Why?
| | Adolescent | 5 | 2024 | 22482 | 0.050 |
Why?
| | Trauma Centers | 1 | 2006 | 469 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1465 | 0.050 |
Why?
| | Erythrocytes | 1 | 2009 | 708 | 0.050 |
Why?
| | Inflammation | 1 | 2014 | 2881 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 220 | 0.050 |
Why?
| | Aged, 80 and over | 4 | 2020 | 8072 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1292 | 0.050 |
Why?
| | Perioperative Period | 1 | 2022 | 70 | 0.050 |
Why?
| | Robotic Surgical Procedures | 1 | 2024 | 154 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 558 | 0.050 |
Why?
| | Platelet Transfusion | 1 | 2022 | 79 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Propensity Score | 1 | 2023 | 350 | 0.040 |
Why?
| | Hemostasis | 1 | 2022 | 100 | 0.040 |
Why?
| | Pandemics | 2 | 2020 | 1668 | 0.040 |
Why?
| | Neoplasm Staging | 2 | 2020 | 1416 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2097 | 0.040 |
Why?
| | Child Abuse | 1 | 2006 | 552 | 0.040 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 10 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 81 | 0.040 |
Why?
| | Partial Thromboplastin Time | 1 | 2020 | 53 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 217 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 92 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2779 | 0.040 |
Why?
| | Blood Viscosity | 1 | 2019 | 18 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 69 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2019 | 40 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2007 | 833 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 720 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 6366 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 390 | 0.040 |
Why?
| | Long-Term Care | 1 | 1999 | 111 | 0.040 |
Why?
| | Ischemia | 1 | 2020 | 416 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2018 | 328 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 347 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2430 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 78 | 0.030 |
Why?
| | Sepsis | 1 | 2022 | 638 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1126 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 4053 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 380 | 0.030 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 28 | 0.030 |
Why?
| | Transplants | 1 | 2015 | 39 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 144 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 76 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 646 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5214 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 1999 | 735 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 159 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 526 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2013 | 846 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 87 | 0.030 |
Why?
| | Macrolides | 1 | 2014 | 69 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1252 | 0.030 |
Why?
| | Femoral Artery | 1 | 2015 | 188 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3109 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 886 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 590 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4182 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 365 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 869 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 219 | 0.020 |
Why?
| | Motivation | 1 | 2018 | 609 | 0.020 |
Why?
| | Reoperation | 1 | 2016 | 605 | 0.020 |
Why?
| | Leukocytes | 1 | 2014 | 299 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2013 | 143 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2856 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2013 | 270 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 273 | 0.020 |
Why?
| | Swine | 1 | 2014 | 837 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1510 | 0.020 |
Why?
| | Infant | 2 | 2021 | 9981 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2013 | 456 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 313 | 0.020 |
Why?
| | Child, Preschool | 2 | 2021 | 11737 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4152 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1117 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2013 | 300 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2009 | 42 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2009 | 136 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 67 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1557 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3380 | 0.020 |
Why?
| | Veterans | 1 | 1999 | 1545 | 0.020 |
Why?
| | Neutrophils | 1 | 2013 | 1134 | 0.020 |
Why?
| | Laparotomy | 1 | 2007 | 116 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 863 | 0.020 |
Why?
| | Intestine, Small | 1 | 2007 | 159 | 0.010 |
Why?
| | Exons | 1 | 2007 | 359 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 861 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1143 | 0.010 |
Why?
| | Blood Preservation | 1 | 2009 | 310 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2007 | 612 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 473 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2531 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 1042 | 0.010 |
Why?
| | Manuals as Topic | 1 | 1999 | 16 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5610 | 0.010 |
Why?
| | Demography | 1 | 1999 | 297 | 0.010 |
Why?
| | Health Resources | 1 | 1999 | 129 | 0.010 |
Why?
| | Patient Admission | 1 | 1999 | 203 | 0.010 |
Why?
| | Nursing Homes | 1 | 1999 | 176 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 1999 | 282 | 0.010 |
Why?
| | Women's Health | 1 | 1999 | 312 | 0.010 |
Why?
| | Colorado | 1 | 2006 | 4658 | 0.010 |
Why?
| | Data Collection | 1 | 1999 | 655 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1999 | 601 | 0.010 |
Why?
| | Internet | 1 | 1999 | 698 | 0.010 |
Why?
| | Sex Factors | 1 | 1999 | 2092 | 0.010 |
Why?
| | Hospitalization | 1 | 1999 | 2313 | 0.000 |
Why?
|
|
Nydam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|